SelectQuote, Inc. Q2 2026 Earnings Recap

SLQT Q2 2026 February 5, 2026

SelectQuote delivered strong Q2 results driven by effective agent productivity and a successful Medicare Advantage season, despite adjusting fiscal 2026 guidance due to external pressures.

Earnings Per Share Beat

$0.26 vs $0.17 est.

+52.9% surprise

Revenue Beat

537102000 vs 530725800 est.

+1.2% surprise

Market Reaction

1-Day -28.97%

5-Day -33.09%

30-Day -35.99%

Key Takeaways

Achieved senior EBITDA margins of 39%, near-record levels, on 4% policy volume growth.
Health care services segment revenues grew 26% year-over-year, validating SelectRx's clinical value.
Entered a strategic multi-year agreement with a key pharmacy benefit manager, enhancing reimbursement visibility.
Announced a new $415 million credit facility, improving capital flexibility for growth initiatives.
Adjusted fiscal 2026 guidance downwards by approximately $40 million due to changes in a key carrier's marketing budget.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit SLQT on AllInvestView.

Previous Q4 2025